CANDOR clinical trial results : Amgen’s Kyprolis extends PFS in multiple myeloma patients

pharmanewsdaily- September 13, 2019 0

CANDOR clinical trial results : Amgen said that a phase 3 study assessing Kyprolis (carfilzomib) in combination with dexamethasone and Johnson & Johnson's Darzalex (daratumumab) ... Read More